Home » Newsletters » BioWorld Science

BioWorld Science

April 1, 1997

View Archived Issues

Antiinflammatory compounds disclosed by Tsumura

Terumo describes antiallergic agents

Antimicrobial agents disclosed by Maruho

Terumo claims platelet aggregation/thromboxane synthase inhibitors

Takeda reports new carbapenems

New antitumor agents from Daiichi

Wakunaga discloses angiotensin II antagonists

Hypoglycemic/hypolipidemic agents from Sankyo

Shaman commences phase II trials of Provir in AIDS-related diarrhea

Novel 5-HT1A agonist described by Asahi Chemical

IGG's lead compound enters the clinic

Genzyme Transgenics receives further funding for development of transgenic ATIII

Nippon Shinyaku presents novel cerebroprotective agent

Extended treatment with Intron A for hepatitis C cleared by FDA

Sumitomo Metal characterizes new antiallergic/antiinflammatory agent

Ares-Serono and Fournier reach U.S. development and marketing agreement for HRT products

Oxford Molecular/PolyMASC collaborate on development of blood growth factor

Neuroprotective effect of hCNTF in primate model of Huntington's disease

First generic warfarin product cleared by the FDA

Fexofenadine introduced in the U.K.

Ciba Vision launches Ophthalin in U.K.

Syrup formulation of Zofran available in the U.K.

U.K. introduction for intranasal sumatriptan

FS069 MAA accepted for review

Cytogen's Quadramet approved by FDA

ICOS initiates phase I with monoclonal antibody

Anaritide and acute renal failure

Gilead's GS-840 enters phase II for chronic hepatitis B treatment

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...